COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT04206787
Brief Title: The START Study Observes Afatinib as First-line Treatment and Sequential Therapy in Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Advanced Nonsmall Cell Lung Cancer

First Submitted : December 11, 2019
First Submitted that Met QC Criteria : December 18, 2019
First Posted : December 20, 2019

Last Update Submitted that Met QC Criteria : January 11, 2021
Last Update Posted : January 12, 2021